Cargando…
A Novel NCI-H69AR Drug-Resistant Small-Cell Lung Cancer Mini-Tumor Model for Anti-Cancer Treatment Screening
Small-cell lung cancer is a fast-growing carcinoma with a poor prognosis and a high level of relapse due to multi-drug resistance (MDR). Genetic mutations that lead to the overexpression of efflux transporter proteins can contribute to MDR. In vitro cancer models play a tremendous role in chemothera...
Autores principales: | van Niekerk, Alandi, Wrzesinski, Krzysztof, Steyn, Dewald, Gouws, Chrisna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416941/ https://www.ncbi.nlm.nih.gov/pubmed/37566059 http://dx.doi.org/10.3390/cells12151980 |
Ejemplares similares
-
Anticancer Potential of Sutherlandia frutescens and Xysmalobium undulatum in LS180 Colorectal Cancer Mini-Tumors
por: Gouws, Chrisna, et al.
Publicado: (2021) -
Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.
por: Reeve, J. G., et al.
Publicado: (1989) -
Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells
por: Zhang, Z, et al.
Publicado: (2013) -
Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism
por: Peterson, Bianca, et al.
Publicado: (2019) -
NIH/NCI Consensus Development Meeting on breast cancer screening. Issues and recommendations.
Publicado: (1978)